Discovering new cell death mechanisms using chemical and genomic
tools
In the Stockwell Lab, we
are illuminating new cell death pathways underlying cancer and neurodegenerative
diseases, using chemical and genomic tools. Our approach is to design
high-throughput screens in mammalian cells that allow us to test tens
of thousands of small organic molecules and small interfering RNAs for
their ability to affect cell death phenotypes associated with cancer
or neurodegeneration. These screens reveal reagents that are used to
identify specific proteins that act as the critical regulators of cell
death decisions. We define the pathways regulating these critical regulators
using protein biochemistry, molecular biology and organic synthesis.
Thus, using a combination of chemical and biological approaches, we
are illuminating new fundamental pathways that are also linked to disease.